Tempest Therapeutics (TPST) Misses Q3 EPS by 79c

Tempest Therapeutics (NASDAQ: TPST) reported Q3 EPS of ($0.79), $0.79 worse than the analyst estimate of $0.00.

For earnings history and earnings-related data on Tempest Therapeutics (TPST) click here.

You May Also Be Interested In

• Trump Bought At Least $100,001 In Palantir Shares, Disclosure Shows - Bloomberg
• Allison Transmission to Join S&P MidCap 400; Goodyear Tire & Rubber to Join S&P SmallCap 600
• XPeng delivers 103,295 vehicles in Q2 2026